Yum Brands CEO tells investors the cyclospora outbreak hurt Taco Bell but sales are improving. He provides no numbers. He provides no timeline. He provides no definition of improving. He just says it and moves on like a man who knows nobody will ask a follow-up question.
Cyclospora is a parasite that lives in human intestines and causes weeks of diarrhea. Taco Bell serves food that people already joke causes diarrhea. The overlap here writes itself. The CDC had to investigate which diarrhea came from which source. Epidemiologists got paid to distinguish between Taco Bell diarrhea and parasite diarrhea. That's their job now.
The CEO says sales are already improving. Already. As if two weeks is a heroic turnaround timeline for convincing people your lettuce won't hospitalize them. He says this on an earnings call where analysts nod and type and nobody asks how many people got sick or which menu items carried the parasite or whether the company changed a single thing about its supply chain. He says improving and the stock ticks up because improving is a word that sounds like money.
Retail traders hear this and think it's a buying opportunity. They think the dip is over. They think Americans have短 memories and strong stomachs and an unshakable loyalty to seventy-nine cent tacos. They're right about all of that. They'll still lose money because they bought shares of a company that just survived a parasite outbreak by saying the word improving on a conference call.
The technical chart doesn't care about cyclospora. It doesn't care about lettuce or supply chains or CEO confidence. It shows support at a level that held before anyone knew what cyclospora was. That level will either hold or it won't. The parasite is irrelevant. The CEO is irrelevant. Your opinion about fast food safety is irrelevant.
But sure, buy the dip on parasite news. Nothing says sound investment strategy like betting on intestinal recovery rates.
Photo by on Unsplash
Leave a Comment